It is well established that high-titer antibodies (≥1:100) are highly specific for autoimmune CASPR2-associated syndromes, including encephalitis, neuromyotonia, and Morvan syndrome (Bien et al., 2017; Wang et al., 2021). This evidence concerns the gene CNTNAP2 and Morvan syndrome.